HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

Abstract Chimeric antigen receptor (CAR) - T cell therapy is a new class of cellular immunotherapies, which has made great achievements in the treatment of malignant tumors. Despite improvements in colorectal cancer (CRC) therapy, treatment of many patients fails because of metastasis and recurrence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jie Xu, Qingtao Meng, Hao Sun, Xinwei Zhang, Jun Yun, Bin Li, Shenshen Wu, Xiaobo Li, Hongbao Yang, Haitao Zhu, Michael Aschner, Michela Relucenti, Giuseppe Familiari, Rui Chen
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/a951c8fcb43d4002b7844f3a23348587
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!